Related Experiment Videos
Protein dimerization between Lmo2 (Rbtn2) and Tal1 alters thymocyte development and potentiates T cell tumorigenesis
R C Larson1, I Lavenir, T A Larson
1MRC Laboratory of Molecular Biology, Cambridge, UK.
The EMBO Journal
|March 1, 1996
Summary
The LMO2 and TAL1 genes interact to promote T cell leukemia. Co-expression in mice accelerates T cell tumor development, confirming TAL1 as an oncogene.
Area of Science:
- Hematology
- Oncology
- Molecular Biology
Background:
- The LMO2 and TAL1 genes are implicated in T cell leukemia through chromosomal abnormalities.
- These genes encode proteins that normally interact during erythroid development.
Purpose of the Study:
- To investigate the synergistic role of LMO2 and TAL1 in T cell tumorigenesis.
- To determine if co-expression of LMO2 and TAL1 promotes T cell leukemia.
Main Methods:
- Generation of transgenic mice co-expressing Lmo2 and Tal1 in T cells.
- Analysis of thymocyte development and tumor formation in transgenic mice.
Main Results:
- Lmo2 and Tal1 proteins formed dimers in double transgenic thymocytes.
- Double transgenic mice showed accelerated T cell tumor development compared to single transgenics.
- Thymuses were populated by immature T cells in double transgenic mice.
Conclusions:
- Interaction between LMO2 and TAL1 proteins alters T cell development and potentiates tumorigenesis.
- The study provides evidence that TAL1 acts as a tumor promoter and oncogene in this system.